- Home
- AORT vs GENI Comparison
AORT vs GENI Comparison
Compare AORT & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AORT | GENI |
|---|---|---|
| Founded | 1984 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.4B |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | AORT | GENI |
|---|---|---|
| Price | $39.61 | $6.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 17 |
| Target Price | ★ $49.36 | $14.18 |
| AVG Volume (30 Days) | 312.9K | ★ 7.4M |
| Earning Date | 02-12-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $422,646,000.00 | ★ $604,524,000.00 |
| Revenue This Year | $15.97 | $30.99 |
| Revenue Next Year | $10.96 | $20.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 9.81 | ★ 30.70 |
| 52 Week Low | $21.97 | $6.00 |
| 52 Week High | $48.25 | $13.73 |
Technical Indicators
Market Signals| Indicator | AORT | GENI |
|---|---|---|
| Relative Strength Index (RSI) | 29.80 | 20.13 |
| Support Level | $39.35 | $6.00 |
| Resistance Level | $41.97 | $8.70 |
| Average True Range (ATR) | 1.37 | 0.56 |
| MACD | -0.23 | -0.34 |
| Stochastic Oscillator | 5.69 | 6.94 |
Price Performance
Historical ComparisonAbout AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.